-
公开(公告)号:DE102005025969A1
公开(公告)日:2006-12-28
申请号:DE102005025969
申请日:2005-06-03
Applicant: BASF AG
Inventor: MONTAG THORSTEN , KARL ULRICH , BAUS ULF , BOLLSCHWEILER CLAUS , SUBKOWSKI THOMAS , LEMAIRE HANS-GEORG , KAROS MARVIN
IPC: C09K3/18 , C02F1/00 , C07K14/375 , C09K5/14
Abstract: In the reduction of evaporation rate of water, thickness of a barrier liquid is less than 1 mm. The barrier liquid has higher boiling point and lower density than the water. An independent claim is included for an open water reservoir.
-
公开(公告)号:AU2006254154A1
公开(公告)日:2006-12-07
申请号:AU2006254154
申请日:2006-05-30
Applicant: BASF AG
Inventor: KAROS MARVIN , BOLLSCHWEILER CLAUS , SUBKOWSKI THOMAS , MONTAG THORSTEN , LEMAIRE HANS-GEORG , BAUS ULF , KARL ULRICH
-
公开(公告)号:DE102005014843A1
公开(公告)日:2006-10-19
申请号:DE102005014843
申请日:2005-03-30
Applicant: BASF AG
Inventor: BECKER HEIKE , BOLLSCHWEILER CLAUS , SUBKOWSKI THOMAS , BAUS ULF , LEMAIRE HANS-GEORG , KAROS MARVIN
IPC: C04B41/46 , C07K14/195
Abstract: Use of hydrophobin (I) for treating surfaces such as hardened mineral building materials, natural stones, artificial stones or ceramics. An independent claim is included for a surface coating comprising (I).
-
公开(公告)号:CA2602158A1
公开(公告)日:2006-10-05
申请号:CA2602158
申请日:2006-03-28
Applicant: BASF AG
Inventor: SUBKOWSKI THOMAS , LEMAIRE HANS-GEORG , BAUS ULF , BECKER HEIKE , BOLLSCHWEILER CLAUS , KAROS MARVIN
Abstract: Use of hydrophobins for treating the surface of cured mineral building materials, natural stone, cast stone or ceramic, a process for treating such surfaces and also surfaces of cured mineral building materials, natural stone, cast stone or ceramic that have a coating comprising hydrophobins.
-
公开(公告)号:DE102005007480A1
公开(公告)日:2006-09-21
申请号:DE102005007480
申请日:2005-02-17
Applicant: BASF AG
Inventor: SUBKOWSKI THOMAS , KAROS MARVIN , LEMAIRE HANS-GEORG , BARG HEIKO , BOLLSCHWEILER CLAUS
Abstract: A new peptide is not connected in a natural manner with an external hydrophobin and has a contact angle of at least 20[deg] during coating of the glass surface. The structural formula of a new polypeptide is: X n-C 1>-X 1-50-C 2>-X 0-50-C 3>-X 1-100-C 4>-X 1-100-C 5>-X 1-50-C 6>-X 0-5-C 7>-X 1-50-C 8>-X m, where X : amino acids; n,m : 0 - 500 and; C : cysteine. The proviso is that at least one of the peptide sequences abbreviated by X n or X m is a peptide sequence of at least 20 amino acids in length. The peptide is not connected in a natural manner with an external hydrophobin and has a contact angle of at least 20[deg] during coating of a glass surface. Independent claims are included for: (1) nucleic acid coding for polypeptide; and (2) procedure of polypeptide production by expressing the above nucleic acid in a host organism and isolating the obtained protein.
-
公开(公告)号:CA2563999A1
公开(公告)日:2005-12-08
申请号:CA2563999
申请日:2005-05-24
Applicant: BASF AG
Inventor: PTOCK ARNE , BOLLSCHWEILER CLAUS , BARG HEIKO , SUBKOWSKI THOMAS , LEMAIRE HANS-GEORG
IPC: C07K19/00 , A61K8/64 , A61K38/17 , A61Q1/02 , A61Q3/00 , A61Q5/00 , A61Q5/02 , A61Q5/06 , A61Q5/12 , A61Q17/04 , A61Q19/00 , A61Q19/04 , A61Q19/10 , C07K14/47
Abstract: The invention relates to novel keratin-binding protein active substances, and also to the production and use thereof. Particularly suitable keratin-binding polypeptides are sequences which are contained in human desmoplakin or are derived therefrom by altering the human desmoplakin polypeptide sequences such as amino acid insertions, substitutions or deletions. The polypeptide sequences of the human desmoplakin is represented in SEQ ID NO: 1. A suitable keratin-binding domain (domain B) is the polypeptide sequence SEQ ID NO: 1, position 2193 2481, in addition to functional equivalents thereof. An additional keratin-binding domain (domain C) is the polypeptide sequence SEQ ID NO: 1, position 2606 2871 and the functional equivalents thereof.
-
公开(公告)号:AU2003273997A1
公开(公告)日:2004-05-13
申请号:AU2003273997
申请日:2003-10-14
Applicant: BASF AG
Inventor: TAEGER TILMAN LUDECKE , PABST GUNTHER , LAMALLE PHILIPPE , BREUER MICHAEL , KROGER BURKHARD , SUBKOWSKI THOMAS , LEMAIRE HANS-GEORG
IPC: C14C1/06
Abstract: Horny substances are removed from animal hides by a process wherein animal hides are treated in a liquor comprising from 0.05 to 5% by weight, based on the salted weight, of one or more compounds of the formula I or the corresponding alkali metal or alkaline earth metal or ammonium or phosphonium salts thereof, the variables being defined as follows: R 1 is selected from hydrogen and C 1 -C 12 -alkyl, unsubstituted or substituted by one or more S-H or O-H groups; X 1 to X 4 are identical or different and are selected from hydrogen, C 1 -C 4 -alkyl, O-H, S-H and N-HR 2 , R 2 is hydrogen or C 1 -C 12 -alkyl or a C 1 -C 4 -alkyl-C-O group, at least one of the radicals X 1 to X 4 being S-H, and, if R 1 contains neither O-H nor S-H, at least one further radical from among X 1 to X 4 is selected from S-H, OH and NH-R 2 , and furthermore with at least one compound which catalyzes the hydrolysis of peptide bonds.
-
公开(公告)号:HRP20010013A2
公开(公告)日:2001-12-31
申请号:HRP20010013
申请日:2001-01-04
Applicant: BASF AG
Inventor: KOCK MICHAEL , HOEGER THOMAS , KROEGER BURKHARD , OTTERBACH BERND , LUBISCH WILFRIED , LEMAIRE HANS-GEORG
IPC: A01K67/027 , A61K38/00 , A61K38/45 , A61K48/00 , A61K49/00 , A61P43/00 , C07K14/455 , C12N1/15 , C12N1/19 , C12N5/10 , C12N9/10 , C12N15/09 , C12N15/54 , C12Q1/68 , G01N33/53 , C12N15/10 , A61K31/70
Abstract: The invention relates to poly(ADP-ribose)polymerase (PARP) homologs which have an amino acid sequence which has a) a functional NAD+ binding domain and b) no zinc finger sequence motif of the general formula CX2CXmHX2C in which m is an integral value from 28 or 30, and the X radicals are, independently of one another, any amino acid; and the functional equivalents thereof; nucleic acids coding therefor; antibodies with specificity for the novel protein; pharmaceutical and gene therapy compositions which comprise products according to the invention; methods for the analytical determination of the proteins and nucleic acids according to the invention; methods for identifying effectors or binding partners of the proteins according to the invention; novel PARP effectors; and methods for determining the activity of such effectors.
-
公开(公告)号:PL345334A1
公开(公告)日:2001-12-17
申请号:PL34533499
申请日:1999-06-04
Applicant: BASF AG
Inventor: KOCK MICHAEL , HOEGER THOMAS , KROEGER BURKHARD , OTTERBACH BERND , LEMAIRE HANS-GEORG , LUBISCH WILFRIED
IPC: A01K67/027 , A61K38/00 , A61K38/45 , A61K48/00 , A61K49/00 , A61P43/00 , C07K14/455 , C12N1/15 , C12N1/19 , C12N5/10 , C12N9/10 , C12N15/09 , C12N15/54 , C12Q1/68 , G01N33/53
Abstract: The invention relates to poly(ADP-ribose)polymerase (PARP) homologs which have an amino acid sequence which has a) a functional NAD+ binding domain and b) no zinc finger sequence motif of the general formula CX2CXmHX2C in which m is an integral value from 28 or 30, and the X radicals are, independently of one another, any amino acid; and the functional equivalents thereof; nucleic acids coding therefor; antibodies with specificity for the novel protein; pharmaceutical and gene therapy compositions which comprise products according to the invention; methods for the analytical determination of the proteins and nucleic acids according to the invention; methods for identifying effectors or binding partners of the proteins according to the invention; novel PARP effectors; and methods for determining the activity of such effectors.
-
公开(公告)号:TR200003624T2
公开(公告)日:2001-06-21
申请号:TR200003624
申请日:1999-06-04
Applicant: BASF AG
Inventor: KOCK MICHAEL , HOEGER THOMAS , KROEGER BURKHARD , OTTERBACH BERND , LUBISCH WILFRIED , LEMAIRE HANS-GEORG
IPC: A01K67/027 , A61K38/00 , A61K38/45 , A61K48/00 , A61K49/00 , A61P43/00 , C07K14/455 , C12N1/15 , C12N1/19 , C12N5/10 , C12N9/10 , C12N15/09 , C12N15/54 , C12Q1/68 , G01N33/53
Abstract: The invention relates to poly(ADP-ribose)polymerase (PARP) homologs which have an amino acid sequence which has a) a functional NAD+ binding domain and b) no zinc finger sequence motif of the general formula CX2CXmHX2C in which m is an integral value from 28 or 30, and the X radicals are, independently of one another, any amino acid; and the functional equivalents thereof; nucleic acids coding therefor; antibodies with specificity for the novel protein; pharmaceutical and gene therapy compositions which comprise products according to the invention; methods for the analytical determination of the proteins and nucleic acids according to the invention; methods for identifying effectors or binding partners of the proteins according to the invention; novel PARP effectors; and methods for determining the activity of such effectors.
-
-
-
-
-
-
-
-
-